CL2017002149A1 - Polypeptide variant that divide fusarium toxins, additives containing these variants and their use, as well as procedures for the division of fusarium toxins. - Google Patents
Polypeptide variant that divide fusarium toxins, additives containing these variants and their use, as well as procedures for the division of fusarium toxins.Info
- Publication number
- CL2017002149A1 CL2017002149A1 CL2017002149A CL2017002149A CL2017002149A1 CL 2017002149 A1 CL2017002149 A1 CL 2017002149A1 CL 2017002149 A CL2017002149 A CL 2017002149A CL 2017002149 A CL2017002149 A CL 2017002149A CL 2017002149 A1 CL2017002149 A1 CL 2017002149A1
- Authority
- CL
- Chile
- Prior art keywords
- well
- fusarium
- variants
- fusarium toxins
- divide
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 6
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 6
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 6
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 title abstract 4
- 241000223218 Fusarium Species 0.000 title abstract 4
- 239000003053 toxin Substances 0.000 title abstract 4
- 231100000765 toxin Toxicity 0.000 title abstract 4
- 108700012359 toxins Proteins 0.000 title abstract 4
- 239000000654 additive Substances 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- MBMQEIFVQACCCH-XVNBXDOJSA-N (S,E)-Zearalenone Chemical compound O=C1OC(C)CCCC(=O)CCC\C=C\C2=CC(O)=CC(O)=C21 MBMQEIFVQACCCH-XVNBXDOJSA-N 0.000 abstract 2
- 230000000996 additive effect Effects 0.000 abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 102000013392 Carboxylesterase Human genes 0.000 abstract 1
- 108010051152 Carboxylesterase Proteins 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Landscapes
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
<p>Variantes de polipéptidos que dividen toxirias de Fusarium de una carboxilesterasa de toxinas de Fusarium con el SEQ ID No. 46, donde las variantes de polipéptidos cuentan con una secuencia de aminoácidos reducida en 47 aminoácidos en el extremo amino terminal y las secuencias de aminoácidos presentan una similitud de al menos un 70 %, preferiblemente un 80 % y más preferiblemente de un 100% de identidad de secuencia, SEQ ID. No. 1 con respecto al tramo de secuencia de aminoácidos 48-540 del SEQ ID No. 46, asi como polinucleótidos aislados que codifican para una variante de polipéptidos, asi como un aditivo que divide toxinas de Fusarium que contiene al menos una variante de polipéptidos y, si es necesario, aI menos una sustancia auxiliar, así como el uso de las variantes de polipéptidos o del aditivo y un procedimiento para Ia division por hidrólisis de al menos una toxina de Fusarium.</p><p> Polypeptide variants that divide Fusarium toxins from a Fusarium toxin carboxylesterase with SEQ ID No. 46, where the polypeptide variants have an amino acid sequence reduced by 47 amino acids at the amino terminal end and the sequences of amino acids have a similarity of at least 70%, preferably 80% and more preferably 100% sequence identity, SEQ ID. No. 1 with respect to amino acid sequence section 48-540 of SEQ ID No. 46, as well as isolated polynucleotides encoding a variant of polypeptides, as well as an additive that divides Fusarium toxins containing at least one variant of polypeptides and, if necessary, at least one auxiliary substance, as well as the use of the polypeptide or additive variants and a method for the division by hydrolysis of at least one Fusarium toxin. </p>
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CL2017002149A CL2017002149A1 (en) | 2017-08-23 | 2017-08-23 | Polypeptide variant that divide fusarium toxins, additives containing these variants and their use, as well as procedures for the division of fusarium toxins. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CL2017002149A CL2017002149A1 (en) | 2017-08-23 | 2017-08-23 | Polypeptide variant that divide fusarium toxins, additives containing these variants and their use, as well as procedures for the division of fusarium toxins. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2017002149A1 true CL2017002149A1 (en) | 2018-04-20 |
Family
ID=63046389
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2017002149A CL2017002149A1 (en) | 2017-08-23 | 2017-08-23 | Polypeptide variant that divide fusarium toxins, additives containing these variants and their use, as well as procedures for the division of fusarium toxins. |
Country Status (1)
| Country | Link |
|---|---|
| CL (1) | CL2017002149A1 (en) |
-
2017
- 2017-08-23 CL CL2017002149A patent/CL2017002149A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR103755A1 (en) | VARIOUS POLYPEPTIDES DIVIDING TOXINS FROM FUSARIUM, ADDITIVE CONTAINING THESE VARIATIONS AND THEIR USE, AS WELL AS PROCEDURES FOR DIVISION OF TOXINS FROM FUSARIUM | |
| CR20200234A (en) | POLYPEPTIDE FOR THE CLEAVAGE OF ZEARALENONE AND / OR DERIVATIVES OF ZEARALENONE, POLYNUCLEOTIDES ISOLATED FROM THE SAME, AND POLYEPTIDE ADDITIVE CONTAINING, USE OF SAID POLIPEPTIDE AND METHOD (Divisional 2016-0128) | |
| MX2017016105A (en) | Adenovirus polynucleotides and polypeptides. | |
| PE20161442A1 (en) | CHEMERICAL PROTEINS TYPE ALKALINE PHOSPHATASE | |
| BR112017020308A2 (en) | udp-glycosyltransferases | |
| BR112018077188A2 (en) | innovative thermostable fructose-6-phosphate-3-epimerase and a method for producing alulose using it | |
| MX2017008449A (en) | PIRINE POLYPEPTIDE AND IMMUNE MODULATION. | |
| BR112015020456A2 (en) | method for operating an electrified self-propelled vehicle and means for its implementation | |
| BR112018077358A2 (en) | innovative thermostable tagatose-6-phosphate phosphatase and a method for producing tagatose using it | |
| CL2023000752A1 (en) | Compositions and methods to treat celiac disease | |
| BR112016016103A2 (en) | COMPOSITION OF MYCOBACTERIAL ANTIGENS | |
| EA201691834A1 (en) | NEW WAY TO CLEAN GONADOTROPINE | |
| CO2019012204A2 (en) | Anti-jagged1 antigen-binding proteins | |
| MX376994B (en) | C-TERMINAL CYCLIC ACETYLCHOLINESTERASE PEPTIDE FOR USE IN THE TREATMENT OR PREVENTION OF CANCER OR METASTASIS. | |
| PE20171783A1 (en) | VARIANTS OF POLYPEPTIDES THAT DIVIDE FUSARIUM TOXINS, ADDITIVE CONTAINING THESE VARIANTS AND THEIR USE, AS WELL AS PROCEDURES FOR THE DIVISION OF FUSARIUM TOXINS | |
| PE20190967A1 (en) | MODIFIED ISOLATED STREPTOMYCES FUNGICIDICUS AND ITS USE | |
| MX2023014326A (en) | PEPTIDES AND METHODS OF USE. | |
| AR100954A1 (en) | BIOACTIVE PROTEIN, USE OF THIS AND METHOD FOR YOUR PRODUCTION | |
| ES2721269T3 (en) | Factors for the production and accumulation of polyunsaturated fatty acids (PUFA) obtained with PUFA synthases | |
| JOP20200066B1 (en) | A method for preparing asymmetric alpha-haloalkanoic acids | |
| AR126935A2 (en) | PROCESS FOR TREATING AN OIL THAT INCLUDES A CHLOROPHYLL SUBSTRATE | |
| MY173772A (en) | Fusarium toxin-cleaving polypeptide variants, additivies containing same, use of same, and method for splitting fusarium toxins | |
| BR112017019625A2 (en) | udp-glycosyltransferases | |
| EA039001B9 (en) | Adenovirus polynucleotides and polypeptides | |
| TH168765A (en) | Polypeptides for Hydrolytic Cutting of Syralenone And / or syralenone derivatives, the isolated polynucleotides of these And also polypeptides containing additives, the use of them and the process |